Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.43 |
| ▸ | LCK | P06239 | 1/20 | 0.43 |
| ▸ | PPARD | Q03181 | 1/20 | 0.43 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.43 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.43 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.42 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.41 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.41 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.39 |
| ▸ | FDPS | P14324 | 3/20 | 0.39 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.39 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.39 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1995402 | 1.00 | LMNA (0.56) | LMNATSHRTHRBDNM1LCK | |
| SCHEMBL10071656 | 1.00 | LMNA (0.56) | LMNATSHRTHRBDNM1LCK | |
| SCHEMBL1990689 | 1.00 | LMNA (0.56) | LMNATSHRTHRBDNM1LCK | |
| SCHEMBL1995024 | 1.00 | LMNA (0.56) | LMNATSHRTHRBDNM1LCK | |
| SCHEMBL19568233 | 1.00 | LMNA (0.56) | LMNATSHRTHRBDNM1LCK | |
| SCHEMBL1437436 | 1.00 | LMNA (0.56) | LMNATSHRTHRBDNM1LCK | |
| SCHEMBL23421276 | 1.00 | LMNA (0.56) | LMNATSHRTHRBDNM1LCK | |
| SCHEMBL17188257 | 1.00 | LMNA (0.56) | LMNATSHRTHRBDNM1LCK | |
| SCHEMBL13165929 | 1.00 | LMNA (0.56) | LMNATSHRTHRBDNM1LCK | |
| SCHEMBL1989574 | 1.00 | LMNA (0.56) | LMNATSHRTHRBDNM1LCK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 302 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119613646-A | Electrochromic material based on organic framework structure and electrochromic device thereof | 宁波祢若电子科技有限公司 | 2025-03-14 | — | — | CN | claimed |
| CN-114874418-B | Conjugated polymer based on trifluoromethyl substituted quinoxaline, and preparation method and application thereof | 广东聚石科技研究有限公司 | 2023-12-19 | — | — | CN | claimed |
| CN-114933609-B | N-type organic semiconductor material based on isoindigo fluorine boron hybridization, preparation method thereof and organic field effect transistor | 青岛科技大学 | 2023-11-14 | — | — | CN | claimed |
| CN-116574084-A | Thiophene derivative and synthetic method and application thereof | 华南理工大学 | 2023-08-11 | — | — | CN | claimed |
| CN-114933609-A | Isoindigo-boron-fluorine-hybridization-based n-type organic semiconductor material, preparation method thereof and organic field effect transistor | 青岛科技大学 | 2022-08-23 | — | — | CN | claimed |
| CN-114874418-A | Conjugated polymer based on trifluoromethyl substituted quinoxaline and preparation method and application thereof | 广东聚石科技研究有限公司 | 2022-08-09 | — | — | CN | claimed |
| CN-110746583-A | Polymer modified by biphenyl sulfur side chain, corresponding photoelectric conversion material, photoelectric conversion element, solar cell and preparation method | 河北科技大学 | 2020-02-04 | — | — | CN | claimed |
| CN-110066287-A | A kind of EDOT- quinoxaline-EDOT derivative and the preparation method and application thereof | 浙江工业大学 | 2019-07-30 | — | — | CN | claimed |
| US-20260085081-A1 | PHOSPHATIDYLAMINE COMPOUNDS INCLUDING A PLURALITY OF TERTIARY AMINO GROUP STRUCTURES AND COMPOSITIONS THEREOF | PEKING UNIVERSITY (CN) | 2026-03-26 | — | — | US | disclosed |
| EP-2768880-B1 | PREPARATION OF HIGH MOLECULAR WEIGHT POLYMERS BY DIRECT ARYLATION AND HETEROARYLATION | UNIV LAVAL (CA) | 2025-11-26 | — | — | EP | disclosed |
| US-20250332112-A1 | IONIZABLE CATIONIC LIPIDS FOR LIPID NANOPARTICLES | GENEVANT SCIENCES GMBH (CH) | 2025-10-30 | — | — | US | disclosed |
| EP-4628494-A1 | PHOSPHATIDYLAMINE COMPOUND COMPRISING MULTIPLE TERTIARY AMINO GROUP STRUCTURES, AND COMPOSITION AND USE THEREOF | Peking University (CN) | 2025-10-08 | — | — | EP | disclosed |
| EP-4583883-A2 | COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF NUCLEIC ACID-BASED THERAPEUTICS AND METHODS THEREOF | Nanotech Pharma Inc. (US) | 2025-07-16 | — | — | EP | disclosed |
| EP-4574172-A2 | IONIZABLE CATIONIC LIPIDS FOR LIPID NANOPARTICLES | GENEVANT SCIENCES GMBH (CH) | 2025-06-25 | — | — | EP | disclosed |
| US-4879388-A | AQUEOUS SOLUTIONS CONTAINING HALIDES | IMPERIAL CHEMICAL INDUSTRIES, PLC (GB) | 1989-11-07 | — | — | US | disclosed |
| US-4775763-A | PYRIDINE ESTER OR AMIDE FOR HYDROMETALLURGY | IMPERIAL CHEMICAL INDUSTRIES (GB) | 1988-10-04 | — | — | US | disclosed |
| US-4683310-A | RECOVERING METALS FROM ORES | IMPERIAL CHEMICAL INDUSTRIES, PLC (GB) | 1987-07-28 | — | — | US | disclosed |
| EP-0057797-B1 | PROCESS FOR THE EXTRACTION OF METAL VALUES AND NOVEL METAL EXTRACTANTS | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1986-06-25 | — | — | EP | disclosed |
| US-4525330-A | SOLVENT EXTRACTION USING ESTER-SUBSTITUTED PYRIDINE OF AQUEOUS HALIDE-CONTAINING SOLUTIONS OF COPPER SALTS | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1985-06-25 | — | — | US | disclosed |
| EP-0057797-A2 | Process for the extraction of metal values and novel metal extractants | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1982-08-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250332112-A1 | IONIZABLE CATIONIC LIPIDS FOR LIPID NANOPARTICLES | CETP, NPC1L1, ABCB4 | LMNA 492/4885TSHR 2640/4885THRB 4440/4885 |
| US-20260085081-A1 | PHOSPHATIDYLAMINE COMPOUNDS INCLUDING A PLURALITY OF TERTIARY AMINO GROUP STRUCTURES AND COMPOSITIONS THEREOF | SGMS1, PHOSPHO1, SGMS2 | LMNA 339/4885TSHR 1172/4885THRB 2484/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.